Edgestream Partners L.P. Has $881,000 Stake in Chemed Corporation (NYSE:CHE)

Edgestream Partners L.P. decreased its stake in shares of Chemed Corporation (NYSE:CHE - Free Report) by 71.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,432 shares of the company's stock after selling 3,575 shares during the period. Edgestream Partners L.P.'s holdings in Chemed were worth $881,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Whipplewood Advisors LLC increased its stake in shares of Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after purchasing an additional 18 shares during the period. Impact Capital Partners LLC boosted its holdings in Chemed by 2.7% during the first quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock worth $469,000 after buying an additional 20 shares in the last quarter. CIBC Private Wealth Group LLC raised its holdings in Chemed by 13.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock worth $98,000 after buying an additional 22 shares during the period. KFG Wealth Management LLC boosted its stake in Chemed by 4.6% in the 1st quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock worth $323,000 after purchasing an additional 23 shares during the period. Finally, First Horizon Advisors Inc. boosted its position in shares of Chemed by 16.1% in the first quarter. First Horizon Advisors Inc. now owns 173 shares of the company's stock worth $107,000 after buying an additional 24 shares during the period. Institutional investors own 95.85% of the company's stock.

Chemed Trading Up 3.1%

CHE stock traded up $14.06 during trading on Wednesday, reaching $466.93. 156,245 shares of the stock were exchanged, compared to its average volume of 112,966. The company has a market capitalization of $6.83 billion, a P/E ratio of 22.74, a price-to-earnings-growth ratio of 2.18 and a beta of 0.50. The stock has a 50 day simple moving average of $526.72 and a 200-day simple moving average of $556.82. Chemed Corporation has a twelve month low of $449.01 and a twelve month high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The firm had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a net margin of 12.40% and a return on equity of 27.58%. The company's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.20 earnings per share. Equities analysts predict that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th were given a dividend of $0.50 per share. The ex-dividend date was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.43%. Chemed's payout ratio is 9.74%.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the company's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $576.45, for a total value of $864,675.00. Following the completion of the sale, the chief executive officer owned 101,197 shares of the company's stock, valued at approximately $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the sale, the executive vice president directly owned 14,627 shares of the company's stock, valued at $8,454,259.73. The trade was a 9.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,500 shares of company stock worth $2,598,450 over the last quarter. 3.29% of the stock is owned by company insiders.

Analysts Set New Price Targets

CHE has been the subject of a number of research reports. Bank of America decreased their target price on shares of Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a research note on Monday, June 30th. Wall Street Zen downgraded shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $640.00 target price (down previously from $674.00) on shares of Chemed in a report on Monday, June 30th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.